Answer
Yes, hair loss (alopecia) is a very common adverse effect of pemigatinib, reported in 49.7% of patients.
Sources for this answer
- Pemazyre 4.5 mg - tabletsIncyte Biosciences UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 5Document updated
Sources checked